Beranda › Sklerosis Multipel Progresif Kronis › Ohio
Uji klinis Sklerosis Multipel Progresif Kronis di Ohio
6 studi untuk Sklerosis Multipel Progresif Kronis mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC), Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07299019A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07840326A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC) L3-100, Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati
- Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland
Menerima pesertaFase 3
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04047628Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT05964829Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.